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CHAPTER 1 
INTRODUCTION 
 
Airway diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, 
and bronchitis may arise from different etiologies but typically progress as a result of chronic 
inflammation (Hargreave and Parameswaran, 2006; Widdicombe and Wine, 2015).  Inflammatory 
reaction to pathogens, irritants, and other stress-related substances is part of a normal protective 
physiological response of the airways which keeps the lung free of pathogens and noxious stimuli.  
Foreign particles inhaled with each breath must be detected and removed to protect the 
airway. It is not surprising then, that a number of systems have evolved to detect and react to 
inhaled particles. Epithelial cells, immune cells and sensory neurons in the airway express 
receptors for noxious stimuli (such as bacterial products, irritants such as capsaicin (CAP), and 
many others). The detection of any of these signals trigger the release of paracrine factors or the 
release of neurotransmitters from nerve endings that in turn initiate an innate immune reaction. A 
central component of the innate airway defence against inhaled pathogens is the airway surface 
liquid (ASL; includes mucus) that facilitates mucociliary clearance.   
During a bacterial infection, the airway epithelia, innate immune cells, and nerve endings 
detect bacterial products, such as lipopolysaccharide (LPS), and trigger the release of various 
inflammatory mediators including cytokines, chemokines, histamines, and eicosanoids that serve 
to recruit innate and adaptive immune responses (Talbot et al., 2016) and to produce copious 
volumes of ASL among other protective functions (Knowles and Boucher, 2002).  
In this thesis, I investigated the effect of inflammatory signals on sensory neurons 
innervating the upper airways. Under inflammatory conditions these sensory neurons increase 
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ASL secretion from airway submucosal glands (SG), the source of ~95% of the ASL in upper 
airways (Wine, 2007). However, the underlying mechanisms that take place in sensory neurons 
under inflammatory conditions remain poorly understood. Therefore, I investigated the cellular 
mechanisms of sensory neuron sensitization in the dorsal root ganglia (DRG) of mice and the role 
of Receptor for Advanced Glycation End-products (RAGE). RAGE expression has been linked to 
chronic airway inflammatory pathologies (Sukkar et al., 2012), thus I have concentrated my 
research on the role of RAGE in mediating the response to bacterial products in modulating 
sensory neuron electrophysiological changes triggered in response to the bacterial product LPS. I 
also investigated changes in RAGE expression and the expression of RAGE variants, generated 
by alternative splicing, triggered by LPS in our preparation. Previous work has shown that in 
humans, murine and canine tissues RAGE undergoes alternative splicing which produces large 
transcriptomic and proteomic diversity of RAGE tissue-specific isoforms, however the 
significance of the spliced variants is unclear (Lopez-Diez et al., 2013).  
Our results show that DRG neurons exposed to inflammatory conditions (i.e. LPS) develop 
a sensitivity to stimulation and produce stronger action potential firing. This response is absent in 
RAGE KO (receptor for advanced glycation end-products-knock out) cells, suggesting that the 
response to LPS is mediated by RAGE. Using mass spectrometry (MS)-based global proteomics, 
I identified the expression of the RAGE isoforms MmusRAGEv1 and v2 (Lopez-Diez et al., 2013) 
specific to airway peripheral neurons under pathological inflammatory conditions (i.e. LPS). Thus, 
taken together, my results may contribute to the understanding of the role of neuronal stimulation 
of ASL hypersecretion in pathological conditions.  
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1.1 Neural innervation of airway SG 
Neuronal stimulation is a major driver of ASL secretion during disease  (Luan et al., 2014; 
Widdicombe and Wine, 2015). Most of the ASL produced in the upper airways emanates from 
airway SGs (Wine, 2007), which secretion is modulated/regulated by the airway intrinsic plexus. 
The airways intrinsic plexus is formed by sensory and autonomic fibers responsible for regulating 
airway function and maintaining homeostasis by compensatory reflexes (Fisher, 1964; Wine, 
2007). Thus, the neural control of the airways is carried by parasympathetic (cholinergic) and 
sympathetic (adrenergic) reflex responses (Fig. 1.1) (Fischer et al., 2009; Hiemstra and Zaat, 
2013).  
ASL secretion by SG is under afferent control. The cell bodies of vagal afferent neurons 
are located in the nodose ganglion, and these neurons relay sensory information to the brain stem 
from which parasympathetic reflexes are initiated (Bautista et al., 2006; Springall et al., 1987; 
Widdicombe and Wine, 2015). In addition, sympathetic afferent and efferent fibers are also found 
in the vicinity of the SGs (Widdicombe and Wine, 2015). Sympathetic afferents travel with their 
efferent counterpart and their cell bodies reside in DRG from the thoracic (T1-T6) regions of the 
spinal cord (Dinh et al., 2004; Qin et al., 2007). Sympathetic and parasympathetic afferent neurons 
display many similarities. Other than their different anatomical locations, they both express typical 
sensory markers such as the transient receptor potential vanniloid 1 (TRPV1), substance P (SP), 
calcitonin gene related peptide (CGRP) and IB4 (Dinh et al., 2004; Plato et al., 2006; Zhang et al., 
2008). It is generally accepted that the parasympathetic afferents have a stronger contribution since 
most of the known airway reflexes can be significantly suppressed by bilateral vagotomy. 
However, it has been recently postulated that these two afferent systems interact synergistically  
during inflammation, and thus, they can play a significant role in the regulation of the airways 
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Figure 1.1    Neural innervation of airway SGs. Airway SGs receive parasympathetic (left) and 
sympathetic (right) inputs. Afferent fibers carry sensory information from the airways via the 
nodose and jugular ganglia to the brainstem nucleus tractus solitarius. Here, interneurons synapse 
with vagal preganglionic fibers that in turn excite intrinsic neuron-mediated SG ASL secretion. 
Sympathetic afferents transmit signals through DRGs from the thoracic segment T1-T4 whose 
axons terminate in Rexed Lamina II (substantia gelatinosa) of the dorsal horn. Interneurons of the 
substantia gelatinosa synapse with Rexed Lamina V efferent fibers that then stimulate SG ASL 
secretion. Reproduced from Widdicombe and Wine (2015). 
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under pathological conditions (Lee and Yu, 2014). 
DRGs are nodule-like structures located in the intervertebral foramina that are dorsolateral 
to the spinal cord which relay information from the external environment to the central nervous 
system (CNS). Neurons within the DRGs are pseudo-unipolar cells with two bifurcations, which 
in the case of thoracic ganglia (tDRG), one projects peripherally to the lungs and heart; and the 
second projects centrally to the dorsal horn of spinal cord. Immunohistological studies on mouse 
lumbar DRGs showed heterogeneous populations of neuronal cell bodies with either unmyelinated 
C- (~70%) or myelinated Aβ-/Aδ- (~30%) fibers (Ruscheweyh et al., 2007) however, these 
proportions are uncertain in tDRGs. Aβ-fibers carry information related to touch and movement 
whereas Aδ-fibers are sensitive to chemical stimuli, noxious gases and inhaled particles, and 
inflammatory and immunologic mediators. C-fibers are sensitive to CAP, cigarette smoke, 
bradykinin, ozone, hypertonic saline and various other chemical stimuli. Both fiber types when 
stimulated produce reflex bronchoconstriction and increased cough to curb further noxious stimuli 
exposure, however, C-fibers can also increase vascular permeability and ASL production (Hamid 
et al., 2005). In the upper airways, afferent nerve endings arborize into the epithelial layer where 
depolarizations from various stimuli are transmitted through the neuronal cell body to vertical and 
radial interneurons (Todd, 2010) in the dorsal horn (Rexed Lamina II) of the spinal cord (Ordovas-
Montanes et al., 2015). Subsequently, interneurons from these laminae dedicated to the modulation 
of noxious and non-noxious stimuli synapse onto Rexed Lamina VII efferent fibers (Todd, 2010). 
The activation of these efferent fibers contribute to the stimulation of ASL secretion from SG and 
also vasodilatation, plasma exudation, neuropeptide release and bronchoconstriction collectively 
termed as ‘neurogenic inflammation’ (Barnes, 2001; Undem and Carr, 2002).  
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1.1.1 Neurogenic inflammation and its contribution to ASL hypersecretion 
In addition to orthodromic inputs to the spinal cord from sensory neurons, action potentials in 
sensory neurons can also be transmitted antidromically at branch points back down to the 
periphery. This constitutes the axon reflex, which together with sustained local depolarizations, 
lead to a rapid and local release of neural mediators from both peripheral axons and terminals 
(Sauer et al., 2001). Classic experiments by Goltz (1874) and Bayliss (1901) showed that 
electrically stimulating DRGs induced skin vasodilation, which led to the concept of a ‘neurogenic 
inflammation’, independent of that produced by the immune system. Neurogenic inflammation is 
mediated mainly by the release of the neuropeptides CGRP and SP from nerve endings, among 
other pro-inflammatory peptides, which act directly on vascular endothelial and smooth muscle 
cells (Brain and Williams, 1989; Edvinsson et al., 1987; McCormack et al., 1989; Saria, 1984). In 
addition to acting on the vasculature, these signals can act directly attracting and activating innate 
immune cells (mast cells, dendritic cells) and adaptive immune cells (T lymphocytes) (Ansel et 
al., 1993; Cyphert et al., 2009; Ding et al., 2008; Hosoi et al., 1993; Mikami et al., 2011; Rochlitzer 
et al., 2011) (see section 1.2). In the acute settings, neurogenic inflammation is protective, 
facilitating physiological wound healing and immune defense against pathogens by activating and 
recruiting immune cells. However, it is also likely to play major roles in the pathophysiology of 
allergic and autoimmune diseases by amplifying pathological or maladaptive immune responses. 
For example, in allergic airway inflammation sensory neurons have been shown to play a central 
role in initiating and augmenting the activation of innate and adaptive immunity (Caceres et al., 
2009; Engel et al., 2011; Ostrowski et al., 2011). 
Some studies suggest that during chronic inflammatory conditions, the DRG neurons of 
the sympathetic afferent pathway, including C-fibers, undergo sensitization (de Groat and 
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Yoshimura, 2009; Janig et al., 1996) which could potentially play a role in SG hypersecretion. 
DRG neurons become sensitized when exposed to pathogens known to affect the airways, such as 
the bacterial LPS. LPS binds to toll-like receptor 4 (TLR4), a member of the pattern-recognition 
receptor (PRR) family, that induces potentiation of TRPV1 currents, increased intracellular Ca2+ 
concentration (Diogenes et al., 2011) and the activation of signaling cascades that result in the 
activation of nuclear factor kappa B (NF-κB) and mitogen-activated protein kinases (MAPKs) (Tse 
et al., 2014). Thus, sensitized efferent sensory C-fibers, that innervate the SGs, can amplify 
inflammation and result in ASL hypersecretion in the airways by axon reflex through the release 
of neuropeptides on the airways during neurogenic inflammation (Barnes, 2001; Barnes et al., 
1998; Maggi et al., 1995). During neurogenic inflammation, nociceptive C-fibers release various 
neuropeptides such as SP, neurokinin-A and CGRP as observed in guinea pig, rat and ferret studies 
through activation with the chilli pepper alkaloid, CAP (Hamid et al., 2005; Millqvist, 2000).  
The role of sensory inflammation in the overproduction of ASL in airway diseases is 
supported by multiple pieces of evidence. For instance, SP is able to stimulate SG secretion in 
human airways in vitro and also goblet cell secretion in guinea pig airways through the activation 
of NK1 (neurokinin 1)-receptors. Other factors that stimulate SG secretion are VIP (vasoactive 
intestinal peptide), cholinergic agonists, elevated cyclic adenosine monophosphate (cAMP), 
elevated Ca2+ and SP-induced acetylcholine release through enhancement of ganglionic 
transmission (Barnes, 2001). Despite evidences of neuropeptidergic factors as the key instigator 
of neurogenic inflammation and subsequent increased SG secretion in animal models, observations 
in in vivo human studies are poorly supportive of this hypothesis.  This deviation may in part be 
due to species-specific pulmonary differences. For example, intra-epithelial SP- and CGRP-
positive fibers make up more than 60% in guinea pigs as opposed to 1% in human airways 
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(Bowden and Gibbins, 1992). Some studies indicated increased SP in bronchial nerves from 
biopsies of fatal asthmatics while other studies were contradictory. Other considerations include 
plasticity-driven increased peripheral nerve innervation during inflammatory states mediated by 
neurotrophins secreted from inflammatory cells that may account for varied observations (Barnes, 
2001). Given such inconsistencies, newer hypotheses have reappraised neurogenic inflammation 
to be the result of both immunological- and neurogenic-driven factors that could contribute to ASL 
hypersecretion. This neuro-immune hypothesis stems from the idea that although neurogenic 
inflammation is protective in the acute phase, chronic states tend to result in pathological or 
maladaptive immune responses (Chiu et al., 2012) which may enhance SG secretions in the airway. 
 
1.2 Cooperative immunogenicity of the peripheral nervous and immune systems 
The early understanding of immunogenicity involved responses of the immune system, excluding 
a role of the peripheral nervous system. However, emerging evidence strongly supports a role of 
the peripheral nervous system, since it shares identical and integrative protective mechanisms with 
the immune system. For instance, both systems express members of the PRR family that recognize 
a variety of highly conserved pathogen-associated molecular patterns (PAMP) (Santoni et al., 
2015; Srikrishna and Freeze, 2009). These receptors, i.e. RAGE and toll-like receptors (TLR), are 
classified under the immunoglobulin (Ig) superfamily of cell surface molecules that initiate and 
amplify responses to inflammation, infection and injury in a tightly-regulated manner (Sukkar et 
al., 2012). However, in pathophysiological scenarios such as in chronic airway inflammation, over-
active PRRs as a result of perturbed endogenous regulatory mechanisms can sensitize sensory 
fibers leading to unwanted consequences (Chiu et al., 2012). Sensory fibers are inherently capable 
of transmitting danger signals more readily than the mobilization of the innate immune system. 
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The high level of organization between neurons and airway structural cells suggests the likelihood 
of direct modification of inflammatory processes in the pulmonary system (McGovern and 
Mazzone, 2014).  
 In fact, research has shown that transient receptor potential cation channel, subfamily A, 
member 1 (TRPA1)-knockout mice that were exposed to the allergen ovalbumin, had no leukocyte 
infiltration in the airways, decreased cytokine and ASL production, and greatly attenuated airway 
hyper-reactivity (Caceres et al., 2009). Moreover, ablation of both TRPA1- and TRPV1-positive 
vagal mouse sensory neurons through genetic or pharmacological means caused a marked 
reduction in airway hyper-reactivity (Ordovas-Montanes et al., 2015). Such evidence suggests an 
intimate link between the peripheral nervous and immune systems. Thus, understanding the 
molecular mechanisms that underlie the coordinated interaction of peripheral neurons and immune 
cells may offer better therapies for airway inflammatory diseases. 
 
1.2.1 RAGE and RAGE isoform expression 
RAGE is a mammalian multiligand transmembrane receptor classified under the Ig superfamily. 
It contains one variable (V)- and two constant (C)-type extracellular domains, a transmembrane 
domain and a cytoplasmic tail (Lopez-Diez et al., 2013). The V-domain which contains two N-
glycosylation sites is the primary binding site for most extracellular ligands. Intracellular signalling 
is mediated by the cytoplasmic tail through a common interaction with Dia-1 (diaphanous-1). Ager, 
the gene that codes for RAGE, is found on the locus for the MHC (major histocompatibility 
complex) Class III region on chromosome 6p21.31 in humans. Gene ancestry and protein mapping 
studies have indicated that Ager evolved from early Metazoans and its encoded protein contains 
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sequences that closely resemble cell adhesion proteins. The latter suggests that RAGE was first a 
cell adhesion protein before evolving into an inflammation-related receptor (Sessa et al., 2014).  
RAGE was initially described as the receptor for advanced glycation end-products (AGEs), 
which form as the result of the non-enzymatic glycation of proteins in the presence of reducing 
sugars (Goldin et al., 2006). However, it is now evident that it also serves as a receptor for the 
calcium binding protein S100/calgranulin superfamily, high mobility group-box protein 1 
(HMGB1), an amyloidogenic isoform of serum amyloid A and amyloid-β peptide (Lopez-Diez et 
al., 2013), and LPS (Rong et al., 2004). These interactions occur in cis, however in trans 
homophilic reactions with RAGE and other unbound RAGE forms, respectively, are also known 
to occur during cell-cell interaction (Sessa et al., 2014). RAGE has been linked to several 
inflammatory-related diseases such as diabetes and metabolic disorders, cardiovascular disorders, 
pulmonary disorders, neurologic disorders, including the aggressiveness of cancers. Cellular 
RAGE expression is readily detectable during embryonic development and decreases significantly 
upon cellular differentiation. Uniquely, this decrease is absent in lung tissue where its expression 
remains high under normal conditions and decreases in pathological states. Non-pulmonary 
differentiated tissues express low levels of RAGE and only increase under inflammatory 
conditions (Sparvero et al., 2009). 
Several RAGE isoforms reported in human, murine and canine studies have revealed that 
variations of the Ig-V-domain can affect extracellular-ligand binding. Moreover, the lack of the 
transmembrane domain can result in a soluble form of RAGE that can be secreted. Isoforms that 
have a signal peptide can also be secreted or inserted into cell membranes. Secreted forms 
generated either through alternative messenger ribonucleic acid (mRNA) splicing or proteolytic 
cleavage of full-length RAGE (Tv1-RAGE) can play dual roles (Lopez-Diez et al., 2013). For 
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example, it can act as a “decoy receptor” in moderating inflammatory responses and can also 
promote inflammatory responses through interaction with Mac-1 (macrophage-1 antigen) 
(Sparvero et al., 2009). Bioinformatics has shown that there are 17 different RAGE isoforms (13 
of which were recently identified – MmusRAGE v1-13) in mice that are expressed in different 
levels in the brain, heart, kidney, liver, lung and pancreas. Tv1-RAGE mRNA contain exons 1 
(SP), 2/3 (IgV domain), 4-6 (IgC2-1), 7-8 (IgC2-2), 9 (non-structural), 10 (transmembrane 
domain) and 11 (cytoplasmic tail). Other membrane-bound (have transmembrane domain) 
isoforms include MmusRAGEv1 and mRAGE_v4. Conversely, likely soluble isoforms include 
MmusRAGEv2 to v6. 
 
1.2.2 Role of RAGE in neurogenic inflammation 
RAGE has been recognized to play a central role in the airway inflammatory process based on 
molecular, biochemical and genomic studies (Mulrennan et al., 2015; Repapi et al., 2010; Sukkar 
et al., 2012). RAGE is ubiquitously expressed, and its up-regulation was firstly implicated in 
diabetes (Hofmann et al., 1999; Neeper et al., 1992; Schmidt et al., 1992; Yan et al., 2010), 
however, it has now been included as part of the pathological mechanisms active in multiple airway 
diseases, such as asthma, COPD, and cystic fibrosis (Buckley and Ehrhardt, 2010; Milutinovic et 
al., 2012). Among the multiple RAGE ligands, LPS, is known to induce ASL secretion through 
the innate immune and peripheral nervous systems (Alexander and Rietschel, 2001; Yamamoto et 
al., 2011; Yanagihara et al., 2001). Brochoalveolar lavage collected from ovalbumin-sensitized 
mice challenged with aerosolized LPS had higher IL-4 (interleukin 4) and tumor necrosis factor α 
(TNF-α) compared to controls (Qiao and Zhang, 2014). Airway epithelia of LPS-treated mice also 
displayed airway cell hyperplasia that is characteristic of airway inflammation (Toward and 
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Broadley, 2002; Vernooy et al., 2002). LPS cultured neonatal rat DRG neurons acutely exposed 
to LPS showed PKC (protein kinase C)-  and PKA (cAMP-dependent protein kinase)-mediated 
CGRP release and increased intracellular Ca2+ (Hou and Wang, 2001). Interestingly, septic shock 
experiments involving RAGE KO mice that were intraperitoneally injected with LPS had 
attenuated serum levels of TNF-α, interleukin 6 (IL-6) and ET-1 (endothelin-1) compared to wild-
type controls. In addition, the same group also showed through binding essays that LPS binds to 
the RAGE (Yamamoto et al., 2011). In humans, increased levels of RAGE have been observed in 
the alveolar walls of patients with COPD, and the up-regulation of RAGE also correlates with the 
expression of HMGB1, a transcription enhancer protein, in asthma patients (Sukkar et al., 2012; 
Zhou et al., 2012). The latter is consistent with the decreased antigen-induced airway inflammation 
and hyporesponsiveness in RAGE KO mice model of asthma (Lee et al., 2013). HMGB1 can bind 
to RAGE and other TLRs to initiate a cascade of events that activate NF-κB which in turn induces 
cytokine production and promotes inflammation. It has been hypothesized that RAGE and TLRs 
may have collaborative signalling through myD88-dependent pathways that tend to elicit stronger 
inflammatory responses than TLR-exclusive pathways (Hall and Agrawal, 2015). The interaction 
between RAGE and its ligands induces reactive oxygen species (ROS) accumulation, probably 
through NADPH (nicotinamide adenine dinucleotide phosphate) oxidase (Ruderman et al., 1992; 
Schmidt et al., 1994; Vincent et al., 2007; Wautier and Schmidt, 2004). Thus, the activation of NF-
κB perpetuates oxidative stress and together with other pro-inflammatory factors generate the 
inflammatory state in neurons (Tobon-Velasco et al., 2014). Alternatively, sensitized RAGE KO 
mice challenged with ovalbumin displayed reduced eosinophilic inflammation and goblet cell 
metaplasia, decreased Th2 (T helper type 2) cytokine production, and lower numbers of pulmonary 
innate lymphoid cells compared to controls (Taniguchi et al., 2015). 
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1.3 Rationale and Hypothesis 
During inflammatory conditions, sensory neurons innervating the SGs in the upper airways 
contribute to ASL secretion. It is not clear however, whether sympathetic afferent neurons play a 
role, and if so, to what extent in the regulation of ASL secretion under inflammatory conditions. 
My working hypothesis is that under inflammatory conditions, RAGE expression and signalling 
mediates tDRG neuron sensitization. In particular, I propose that exposure to LPS will cause an 
increase in CAP-evoked current parameters in neurons from WT mice, but these changes will not 
be expected in neurons from RAGE KO mice. Similarly, we propose that evoked action potential 
generation will be increased in neurons from WT, but not from RAGE KO, mice when exposed to 
LPS. Furthermore, I propose that changes in the expression pattern of RAGE isoforms underlie 
the sensitization of tDRG neurons during LPS exposure. Here, I expect to see an increase in full 
length RAGE (Tv1-RAGE) expression, however the expression pattern of RAGE isoforms in 
membrane and cytosolic fractions is unknown and cannot be speculated.  
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CHAPTER 2 
MATERIALS & METHODS 
 
2.1 Animals. A colony of RAGE KO mice on a C57BL/6 background was maintained by 
breeding heterozygous mice as previously described (Chandna et al., 2015). Heterozygous mice 
were generated by back-crossing RAGE KO (homozygous) mice (Myint et al., 2006) with 
C57BL/6 wild type (WT) mice. All experiments were based on tDRGs (T1-T4) from homozygous 
(RAGE KO) mice and their C57BL/6 (wild type) littermates. Mice were genotyped using genomic 
DNA (deoxyribonucleic acid) and PCR (polymerase chain reaction) as previously described 
(Myint et al., 2006) but with slight modifications. Briefly, ~2 mm of mouse tail was digested for 
30 mins at 95oC in 300 µL digestion buffer (0.5 M EDTA (ethylenediaminetetraacetic acid) and 
50% NaOH dissolved in distilled water). Samples were chilled on ice for 5 mins before the addition 
of 75 µL neutralization buffer (40 mM Tris-HCl (tris hydrochloride)). Samples were vortexed 
briefly and 2 µL was used for PCR (20 µL reaction) (Truett et al., 2000). PCR reactions were run 
on 2% agarose gels containing 0.5 µg/mL ethidium bromide and visualized on a UV (ultraviolet)-
illuminated gel box. All in vitro experiments were done with neonatal pups (P0–P4). This work 
was approved by the University of Saskatchewan’s Animal Research Ethics Board (Campanucci: 
protocol 20090082) and adhered to the Canadian Council on Animal Care guidelines for humane 
animal use. 
 
2.2 Primary tDRG cultures. Bilateral tDRG (T1-T4) neurons were harvested and cultured 
from neonatal (P0-P4) mice as previously described for peripheral neurons (Campanucci et al., 
2008). tDRG neurons were selected as they are known to innervate the upper airways 
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(Widdicombe and Wine, 2015). Briefly, ganglia were removed under sterile conditions and 
enzymatically dissociated at 37°C in HBSS (Hanks’ balanced salt solution) containing trypsin 
(180–200 U/mL; Worthington, Freehold, NJ, USA) and buffered with HEPES (N-2-
hydroxyethylpiperazine-N-2-ethane sulfonic acid; pH 7.4). The resulting cell suspension was 
washed twice in serum-containing Leibovitz's L-15 medium to inactivate the trypsin and plated on 
laminin-coated glass bottom petri dishes (35 mm) made in-house. The neurons were grown in L-
15 medium supplemented with vitamins, cofactors, penicillin–streptomycin, 5 mM glucose, 5% 
rat serum and NGF (nerve growth factor; 10 ng/mL). Cultures were maintained at 37°C in a 
humidified atmosphere of 95 % air-5 % CO2 and fed every 4 days with growth media. To eliminate 
non-neuronal cells, cultures were treated with cytosine arabinoside (10 μM; Sigma-Aldrich, St. 
Louis, MO, USA) from days 2 to 4. Established DRG cultures were incubated for 24h at 37oC; 
(5% CO2; humidified) in growth media alone (control), with a cytokine cocktail (CC) consisting 
of 1.5 nM IL-6 (Murata et al., 2011; Suto et al., 1993), 1.5 nM IL-8 (interleukin 8) (Dong et al., 
2012), 3 nM TNF-α (Hensellek et al., 2007) and 0.6 µM IL1-β (interleukin 1 beta) (Saleh et al., 
2013) or with 1µg/mL LPS (Sigma-Aldrich)-supplemented growth media. Both CC and LPS pro-
inflammatory inducers were tested in WT tDRGs for their ability to produce robust and 
reproducible CAP-evoked currents that were indicative of inflammation (increased peak 
amplitude, current density and charge). Of these two inducers, I chose LPS for this study as it not 
only met the requirements mentioned but was also easier to prepare. 
 
2.3 Whole-cell Patch Clamp Electrophysiology. Medium-sized tDRG neurons (~25-35 µm) 
were selected for whole-cell recording. Membrane currents were recorded with an Axopatch 200B 
amplifier (Molecular Devices, Palo Alto, CA, USA) equipped with a 1 GΩ cooled head-stage 
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feedback resistor and a Digidata 1400A analog-to-digital converter (Molecular Devices), and 
stored on a personal computer. Current- and voltage-clamp protocols, data acquisition, and 
analysis were performed using pClamp 10 (Molecular Devices) and Origin 9.0 software 
(OriginLab Corporation, Northampton, MA, USA). Patch pipettes were made using thin-wall 
borosilicate glass capillaries (World Precision Instruments, FL, USA) using a vertical puller (PC 
10; Narishige Scientific Instrument Lab., Tokyo, Japan) and polished with a microforge 
(Narishige) to a final resistance of 3–8 MΩ when filled with intracellular recording solution. In 
most experiments, 75% of the series resistance was compensated, and junction potentials were 
cancelled at the beginning of the experiment. Recording electrodes were filled with the following 
intracellular solution (in mM): 65 KF, 55 KC2H3O2, 5 NaCl, 0.2 CaCl2, 1 MgCl2, 10 EGTA 
(ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid), 2 MgATP (adenosine 5'-
triphosphate magnesium salt) and 10 HEPES, and pH was adjusted to 7.2 with KOH (all from 
Sigma-Aldrich). Cultured neurons were perfused continuously at 1 mL/min with control perfusion 
solution consisting of (in mM): 140 NaCl, 5.4 KCl, 0.33 NaH2PO4, 0.44 KH2PO4, 2.8 CaCl2, 0.18 
MgCl2, 10 HEPES, 5.6 glucose, 2 glutamine, 0.001% atropine and 5 μg/mL phenol red; pH was 
adjusted to 7.4 with NaOH (all from Sigma-Aldrich). Whole-cell patched neurons were allowed 
to stabilize for 5 min before recording. Action potentials were generated in current-clamp mode 
by injection of a series of depolarizing current steps at 100 pA increments for 500 ms. All other 
experiments were carried out under voltage-clamp mode. A fast-step perfusion system was used 
to deliver either control or CAP (1µM)-containing extracellular solution at 1 mL/min perfusion 
rate. 
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2.4 MS-based proteomic analyses. MS-based proteomic analysis was used to study global 
protein changes in tDRG neurons from WT mice in control or LPS conditions. This method was 
preferred over Western Blotting or qPCR (quantitative polymerase chain reaction) because no 
RAGE isoform-specific antibodies are available and qPCR is unable to detect posttranslational 
modifications, respectively.  
Suspensions of cultured tDRG neurons from WT and RAGE KO mice were prepared as 
described above, and plated onto specialized cell culture dishes (Sarstedt, Nümbrecht, Germany). 
We used approximately 80,000 cells per experimental group (control or LPS), each plating is 
generated from 20 pups. Membrane and soluble fractions from cultured tDRG neurons were 
obtained using the ProteoExtract Native Membrane Protein Extraction Kit (EMD Millipore, MA, 
USA) and processed as per the manufacturer’s instructions and stored at -80oC. Protein 
concentrations were determined by Nanodrop analysis with a BioTek Synergy HY multi-detection 
plate reader (Winooski, VT, USA).  
 
2.4.1 In-solution Digestion. Protein samples were concentrated by acetone precipitation. To 
precipitate proteins, 4x sample volume of cold (-80⁰C) acetone was added to an aliquot from lysate, 
vortexed, and incubated overnight at -80⁰C. Then samples were centrifuged 13000 x g at 4⁰C for 
15 min. After washing protein pellets twice with cold (-80⁰C) 80% acetone/20% water, protein 
pellets were air dried and re-suspended in 55 µL trifluoroethanol (TFE) buffer (10% TFE, 100 mM 
ammonium bicarbonate (ABC)). Proteins were digested in-solution using an in-house developed 
protocol. Briefly, 45 µL of each protein sample was placed in 1.5 mL tube and diluted with 5 µl 
of 100 mM ABC buffer (Fisher Scientific, Fair Lawn, NJ, USA) and 50 µL TFE (Fisher Scientific) 
to denature proteins. The samples were treated with 1 µL of 1M DTT (dithiothreitol) (MP 
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Biomedicals, Solon, OH, USA) while shaking at 300 RPM (Eppendorf Thermomixer, Eppendorf, 
Mississauga, ON, Canada) at 60oC for 60 min to reduce disulfide bonds formation. Next, samples 
were alkylated with 100 µL of 110 mM iodoacetamide (IAA; Fisher Scientific) at 37oC for 30 min 
on a shaker, covered with aluminum foil, to prevent further disulfide bond formation. The samples 
were dried in a speedvac (Labconco, Kansas City, MO, USA). Proteins in the samples were treated 
with 1 mL cold acetone followed by refrigeration at -80oC for 60 min to eliminate salts and other 
interfering compounds (e.g. detergents), which can prevent digestion. The samples were 
centrifuged twice at 18000 x g for 30 min and acetone was carefully removed. Next, samples were 
dried in a speedvac and a buffer-containing trypsin (Promega Corporation, Madison, WI, USA) 
solution (50 ng/µL trypsin in 1 mM HCl (hydrochloric acid) /100 mM ABC) was added to the 
samples in a 40:1 protein:trypsin. The samples were incubated in a shaker at 300 RPM overnight 
at 37oC. Trypsin buffer at the same ratio was added again in the morning to ensure complete 
digestion of proteins into peptides. After 2 hrs of further incubation at 37oC, digested peptides 
were dried in speedvac and stored at -80oC until further analysis.  
 
2.4.2    Strong Cation Exchange (SCX)-based Fractionation. SCX-based fractionation was 
performed using SCX SpinTips sample prep kit (Protea Biosciences, Morgantown, WV, USA). 
The digested protein samples were dissolved in 200 µL of SCX reconstitution solution, a pH of 3 
was adjusted with formic acid (FA). The samples were then loaded on to SCX SpinTip and 
centrifuged at 2000 x g for 6 min. To enhance peptide binding to SCX SpinTip samples were 
centrifuged 3 times. The flow through at the end of the step was transferred to a 1.5 mL tube for 
MS analysis. Peptides bound to SCX column were eluted using stepwise concentrations (in M): 
20, 40, 60, 80, 100, 150, 250, 500 of ammonium formate (Sigma-Aldrich) in 10% acetonitrile 
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(ACN; Fisher Scientific) at pH 3. 150 µL of ammonium formate (in increasing concentrations) 
was added to the SpinTip and centrifuged at 2000 x g for 6 min. The flow through was collected 
after every centrifugation and transferred to 1.5 mL tube. All flow through were dried in speedvac 
and stored at -80oC.  
 
2.4.3     MS Workflow. All SCX fractions containing tryptic peptide were reconstituted in 20 µl 
of MS grade water:ACN:FA (97:3:0.1 v/v) followed by vortexing for 1-2 min.  The resulting 
solutions were centrifuged at 18000 x g for 10 min at 4ºC. 15 µL aliquot of each sample was 
transferred to a mass spectrometry vial (Agilent Technologies Canada Ltd., Mississauga, ON, CA) 
for liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. All MS analyses 
were performed on an Agilent 6550 iFunnel quadrupole time-of-flight (QTOF) mass spectrometer 
equipped with an Agilent 1260 series liquid chromatography instrument and a Chip Cube LC-MS 
(liquid chromatography-mass spectrometry) interface (Agilent Technologies).  Chromatographic 
peptide separation was accomplished using a high-capacity high performance liquid 
chromatography (HPLC)-Chip II: G4240-62030 Polaris-HR-Chip_3C18 consisting of a 360 nL 
enrichment column and a 75 µm × 150 mm analytical column, which were both packed with 
Polaris C18-A, 180Å, 3 µm stationary phase. Samples were loaded onto the enrichment column 
with 50% solvent A (0.1% FA in water) and 50% solvent B (0.1% ACN:FA) at a flow rate of 2.0 
µL/min. Samples loaded to enrichment column were transferred onto analytical column, and 
peptides were separated with linear gradient solvent system. The linear gradient program was 
employed for peptide separation with solvent A and solvent B on an analytical column. The linear 
gradient is 3–25% solvent B for 50 min and then 25–90% solvent B for 10 min at a flow rate of 
0.3 µL/min. Positive-ion electrospray MS data was acquired using a capillary voltage set at 1900 
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V, the ion fragmentor set at 360 V, and the drying/collision gas (nitrogen) set at 225ºC with a flow 
rate of 12.0 L/min.  Spectral results were collected over a mass range of 250–1700 mass/charge 
(m/z) at a scan rate of 8 spectra/sec. Tandem mass spectrometry (MS/MS) data were collected over 
a range of 100–1700 m/z and a set isolation width of 4 atomic mass units.  The top 20 most intense 
precursor ions for each MS scan were selected for MS/MS with active exclusion for 0.25 min. To 
clarify, precursor ions are of a specific m/z ratio in the first stage (MS) of MS/MS. These ions will 
then undergo collision-induced dissociation using nitrogen gas in the second stage (MS/MS) of 
MS/MS. 
 
2.4.4     Protein Identification. Spectral data were converted to a m/z data format using Agilent 
MassHunter Qualitative Analysis Software (Agilent Technologies) and were processed against the 
NCBI (National Center for Biotechnology Information) non-redundant Mus musculus database, 
using SpectrumMill (Agilent Technologies) as the database search engine.  Search parameters 
included a fragment mass error of 50 parts per million (ppm), a parent mass error of 20 ppm, 
trypsin cleavage specificity, and carbamidomethyl as a fixed modification of cysteine.  In addition, 
four stages of database search in variable modification mode were carried out with different sets 
of variable modifications. In first stage, carbamylated lysine, oxidized methionine, pyroglutamic 
acid, deamidated asparagine and phosphorylated serine, threonine, and tyrosine were set as 
variable modifications.  In the second stage, validated hits from the first stage were searched using 
the following variable modifications: acetyl lysine, oxidized methionine, pyroglutamic acid, 
deamidated asparagine, and phosphorylated serine, threonine, and tyrosine. The validated hits from 
the second stage were searched using semi-trypsin non-specific C-terminus, yielding the third 
stage validated hits, which were subsequently searched using semi-trypsin non-specific N-
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terminus (fourth stage), with no other variable modifications specified. After each stage, Spectrum 
Mill validation was performed at peptide and protein levels (1% false discovery rate).  
Protein samples were reduced, alkylated and digested with trypsin in-solution in 
accordance with a modified version of a previously published protocol (Zhang et al., 2011). Tryptic 
peptides were analyzed by LC-MS/MS using an Agilent HPLC Chip/6550 iFunnel QTOF mass 
spectrometer (Agilent Technologies). MS/MS were referenced against the mouse NCBI non-
redundant database and a custom database (containing mouse RAGE protein isoforms) using 
Spectrum Mill (Fig. 2.1). Spectral counts were used to report relative quantitation of proteins. 
 
2.4.5     Manual Identification of Unique Modified RAGE isoforms (see Fig. 2.1). For either 
genotype, tryptic peptides identified in each RAGE isoform from the custom database in each 
treatment group were sorted according to their sequences. Then, common and duplicate peptides 
found in 2 or more RAGE isoforms were discarded leaving behind unique peptides that were 
specific to a particular RAGE isoform. Finally, these peptides were further specified according to 
their post-translational modifications. 
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Figure 2.1 Processing of MS/MS spectra in the identification of unique post-
translationally modified RAGE isoform peptides in WT tDRG neurons under control and 
LPS treatment conditions.  
MS/MS Spectra referenced against 
mouse NCBI non-redundant database 
Result: Canonical RAGE isoform 
identified. No isoforms identified 
 
 
MS/MS Spectra referenced against 
mouse custom database 
Result: Several RAGE isoforms identified 
 
 
Manually sorted peptides from each 
isoform by amino acid sequence. 
Duplicates and common peptides from 2 
or more RAGE isoforms eliminated. 
Result: Peptides specific to a particular 
RAGE isoform identified. However, some 
of these peptides had post-translational 
modifications specific to either 
membrane or cytosolic, and control or 
LPS treatment 
 
 
Manually sorted peptides by post-
translational modification 
Result: Identified peptides specific to a 
particular RAGE isoform, fraction and 
treatment.  
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2.5 Statistical Analyses. We compared the EC50 (half maximal effective concentration) 
obtained from the dose response curves using tDRG neurons from either WT and RAGE KO, by 
unpaired t-test with Welch correction. In voltage-clamp experiments, raw values of peak 
amplitude, current density and charge of CAP-evoked current were compared using the unpaired 
t-test with Welch correction. In current-clamp experiments, action potential counts were compared 
using Mann-Whitney test. Resting membrane potentials (VRM) were compared using the Kruskal-
Wallis test (non-parametric analysis of variance, ANOVA). The significance threshold was set at 
0.05 for all statistical tests performed. 
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CHAPTER 3 
RESULTS 
 
3.1 Determination of working concentration for CAP-evoked currents  
In order to test the possible sensitization of sensory neurons exposed to inflammatory conditions 
(i.e. LPS-treatment or cytokines), we studied  neuronal  excitability in response to the injection of 
depolarizing current and to applications of the agonist CAP. Thus, to determine a submaximal 
working concentration of CAP, that would allow us to observe potential increases or decreases in 
whole-cell currents, we generated a dose-response curve to increasing concentrations of CAP in 
tDRG cultured neurons from WT and RAGE KO mice (Fig. 3.1). Cultured neurons were briefly 
exposed to CAP (0.1, 0.5, 1, 2.5, 5 and 10 µM; 1s) and the data were fitted with a logistic Hill 
function (R2=0.93746 for WT, and R2=0.94002 for RAGE KO). The EC50 of CAP obtained in 
cultures from WT and RAGE KO mice was 1.50 ± 0.44 µM and 2.25 ± 0.81 µM, respectively.  No 
significant difference (p>0.05) was found in the EC50 values between the two genotypes. 
Subsequently, 1 µM CAP was selected as the submaximal working concentration throughout the 
study.  
 
3.2  Exposure of sensory neurons to cytokines cocktail induces sensitization of CAP-
evoked currents 
Cultured tDRG neurons from WT mice were incubated in either control or cytokine cocktail (CC)-
containing growth media (for 24 hr) before whole-cell recording of CAP-evoked currents. The 
mean peak amplitude of CAP-evoked currents in CC-treated neurons (-1063.51 ± 170.34 pA) was 
significantly higher (p<0.05) than in control neurons (-554.04 ± 64.01 pA) (Fig. 3.2A, B). Mean  
25 
 
 
 
 
 
Figure 3.1  Dose-response of CAP-evoked currents in WT and RAGE KO DRG neurons. 
Dose dependency of CAP-evoked currents from cultured tDRG neurons from wild-type (WT) and 
RAGE-knockout (RAGE KO) mice (P0-P4) obtained by whole-cell patch clamp 
electrophysiology. DRGs neurons were clamped at -60mV and exposed to CAP for 1s. Data points 
indicate mean current density (pA/pF) at 0.1 (n = 6 for each genotype), 0.5 (WT=7; RAGE KO=6), 
1 (WT=11; RAGE KO=10), 2.5 (WT=6; RAGE KO=7), 5 (WT=5; RAGE KO=8) and 10 µM CAP 
(WT=5; RAGE KO=7). The data were fitted with a logistic Hill function – WT R2=0.93746; 
RAGE KO R2=0.94002. Error bars indicate mean ± SEM. The EC50 of CAP in wild-type and 
RAGE KO was 1.50 ± 0.44 µM and 2.25 ± 0.81 µM, respectively.  
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Figure 3.2 CC exposure increases CAP-evoked currents in tDRG neurons from WT 
neonatal mice. The CC consisted of 1.5 nM IL-6 (Murata et al., 2011; Suto et al., 1993), 1.5 nM 
IL-8 (Dong et al., 2012), 3 nM TNF-α (Hensellek et al., 2007) and 0.6 µM IL1-β (Saleh et al., 
2013). (A) Representative CAP (1 µM; 1 s)-evoked current traces (VH = -60 mV) from cultured 
wild type (WT) tDRGs. (B) Mean peak amplitude (pA), (C) current density (pA/pF) and (D) 
charge (1 x 106  pC) graphs of WT DRG neurons exposed to either control or CC-containing media 
(24h). Treatment groups (mean peak amplitude, mean current density, mean charge): WT control 
(13); WT CC (10). Error bars indicate mean ± SEM. Letter ‘a’ denotes p<0.01 and ‘c’ denotes 
p<0.05 based on unpaired t-test with Welch correction. Control group is abbreviated as ‘CTRL’. 
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current density was significantly higher (p < 0.05) in the CC group (-31.73 ± 6.13 pA/pF) 
compared to controls (-16.19 ± 2.16 pA/pF) (Fig. 3.2A, C). The mean charge was significantly 
higher (p < 0.01) in the CC group (2.70 ± 0.35 x 106 pC) compared to controls (1.26 ± 0.22 x 106 
pC) (Fig. 3.2A, D). The results indicate that DRG neurons exposed to proinflammatory cytokines, 
modeling the conditions of a diseased airway, develop sensitization and become hyperresponsive 
to stimulation.  
 
3.3 RAGE expression is required for the potentiation of CAP-evoked currents in tDRG 
neurons 
To generate inflammatory conditions that are physiologically more relevant to airways pathology, 
we expossed cultured tDRG neurons to the bacterial endotoxin LPS. Thus, cultured neurons from 
WT and RAGE KO mice were incubated in either control or LPS-containing growth media (for 
24 hr) before the recording of whole-cell CAP-evoked currents. Consistent with our results with 
the CC-containing media, the mean peak amplitude of CAP-evoked currents in LPS-treated 
neurons from WT mice (-1188.54 ± 177.76 pA) was significantly higher (p<0.01) than in control 
neurons (-554.04 ± 64.01 pA) (Fig. 3.3A, B). To account for neuronal size we calculated the mean 
current density, which was significantly higher (p < 0.005) in the LPS group (-49.49 ± 7.38 pA/pF) 
compared to controls (-16.19 ± 2.16 pA/pF) (Fig. 3.3A, C). Consistently, the mean charge was 
significantly higher (p < 0.005) in the LPS group (2.70 ± 0.35 x 106 pC) compared to controls (1.26 
± 0.22 x 106 pC) (Fig. 3.3 A, D). Contrasting with our results in neurons from WT mice, tDRG 
neurons from RAGE KO mice did not exhibit significant differences in CAP-evoked currents in 
the LPS group compared to controls (p>0.05) (Fig. 3.3A-D). Mean peak amplitude for control 
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group was 282.13 ± 43.79 pA and LPS-treated group was 349.77 ± 41.71 pA (Fig 3.3A, B). Mean 
current density for control (-9.00 ± 0.88 pA/pF) and LPS-treated (–10.94  
 
 
 
Figure 3.3 LPS exposure increases CAP-evoked currents in tDRG neurons from WT 
neonatal mice. (A) Representative CAP (1 µM; 1 s)-evoked current traces (VH = -60 mV) from 
cultured wild type (WT) and RAGE-knockout (RAGE KO) tDRGs. (B) Mean peak amplitude 
(pA), (C) current density (pA/pF) and (D) charge (1 x 106  pC) graphs of WT and RAGE KO DRG 
neurons exposed to either control or LPS-containing media (1 µg/mL; 24h). Treatment groups 
(mean peak amplitude, mean current density & mean charge): WT control (13); WT LPS (9); 
RAGE KO control (8); RAGE KO LPS (9; Exception: n=8 for Mean Charge in RAGE KO LPS 
group). Error bars indicate mean ± SEM. Letter ‘a’ denotes p<0.01 and ‘b’ denotes p<0.005 based 
on unpaired t-test with Welch correction. Control group is abbreviated as ‘CTRL’. 
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± 1.14 pA/pF) groups (Fig. 3.3 A, C) were not significantly different (p>0.05). Similarly, the mean 
charges for the control group (0.86 ± 0.20 x 106 pC) was not significantly different (p>0.05) from 
the LPS-treated group (1.07 ± 0.18 x 106 pC) (Fig. 3.3A, D). 
 
3.4 RAGE expression is required to increase neuronal excitability in tDRG neurons  
To test neuronal excitability we generated action potentials in cultured tDRG neurons from WT 
and RAGE KO mice, mantained in either in control or LPS conditions. We quantified action 
potentials generated by the injection of depolarizing current steps (0 to 1000 pA, at 100pA 
increments; Fig. 3.4). Cultured tDRG neurons from WT mice treated with LPS displayed a 
significant (p<0.05) increase in mean action potential counts at 200pA (5.08 ± 0.96 counts) 
compared to controls (2.42 ± 0.56 counts; Fig. 3.4A, B). In contrast, there were no significant 
(p>0.05) differences in action potential counts between the control (2.63 ± 0.60 counts) and LPS 
groups (2.45 ± 0.58 counts) in tDRG neurons from RAGE KO mice (Fig. 3.4A, C). There were no 
significant differences (p>0.05) in mean resting membrane potentials in WT and RAGE KO tDRG 
neurons under control and inflammatory conditions (Table 3.1). 
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Figure 3.4  LPS exposure increases cell excitability in DRG neurons from WT mice. (A) 
Representative action potential traces in response to injection of depolarizing current steps (0 to 
1000 pA, at 200 pA increments). Mean action potential counts generated in tDRG neurons exposed 
to either control or from (B) WT and (C) RAGE KO groups (control and LPS). Error bars represent 
mean ± SEM. Letter ‘c’ denotes p<0.05 based on Mann-Whitney Test. (D) Step current injection 
protocol used in whole-cell current-clamp electrophysiology experiments. Treatment groups: WT 
control (12); WT LPS (12); RAGE KO control (16); RAGE KO LPS (11). Control group is 
abbreviated as ‘CTRL’. 
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TREATMENT GROUP 
 
WT CTRL WT LPS WT CC 
RAGE KO 
CTRL 
RAGE KO 
LPS 
Mean VRM ± SEM (mV) -44.65 ± 2.43 -48.20 ± 2.32 -44.37 ± 2.25 -47.28 ± 1.56 -47.66 ± 1.88 
 
 
Table 3.1 Mean VRM of WT and RAGE KO tDRG neurons under control and 
inflammatory conditions. Combined mean resting membrane potential of WT and RAGE KO 
experimental groups recorded in voltage- (excluding dose-response experiments) and current-
clamp experiments. Treatment groups: WT CTRL (25); WT LPS (21); WT CC (10); RAGE KO 
CTRL (24) and RAGE KO LPS (20). Raw values from each treatment group were compared using 
the Kruskal-Wallis Test (non-parametric ANOVA) and found to be not significantly different 
(p>0.05). Control group is abbreviated as ‘CTRL’. 
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3.5 Expression profile of RAGE and its isoforms in tDRG neurons exposed to LPS 
In this study, we detected an increase in expression levels of full length RAGE (Tv1-RAGE; 41.1 
arbitrary units, a.u.) in tDRG neurons from WT mice exposed to LPS, with respect to control (26.3 
a.u.) (Fig 3.5). Next, I investigated the expression of specific RAGE isoforms under different 
experimental conditions. This was done by identifying and mapping specific peptides to regions 
of the respective RAGE isoforms (Table 3.2). Peptides mapped to the N-terminus of 
MmusRAGEv1 (membrane-bound) and C-terminus of MmusRAGEv2 (soluble), confirmed the 
expression of these two RAGE isoforms in tDRG neurons from WT mice. However, other peptides 
failed to map uniquely to other isoforms, and further bioinformatics analysis will be needed to 
identify their presence. Therefore, only data for isoforms MmusRAGEv1 and v2, and only those 
with the highest intensity were included (Fig 3.6A, B). In WT tDRG neurons (Fig. 3.6A) under 
control conditions, the membrane fraction revealed MmusRAGEv1 and v2 levels to be 0.10 a.u. 
and 2.03 a.u., respectively. In the membrane fraction of LPS-treated neurons, MmusRAGEv1 was 
not detected and MmusRAGEv2 decreased (0.75 a.u.) relative to controls. In the cytosolic fraction, 
5.38 a.u. MmusRAGEv1 was detected in control, and no MmusRAGEv2 was detected. The 
cytosolic fraction of LPS-treated neurons showed a decrease in MmusRAGEv1 (2.74 a.u.) and an 
increase in MmusRAGEv2 (1.35 a.u.), relative to controls. In addition, peptides mapped to the 
MmusRAGEv1 and v2 revealed posttranslational modifications (Figure 3.6B). Our findings show 
that Thr5 (threonine 5 residue) of MmusRAGEv1 was phosphorylated in the membrane fractions 
while Thr12 (threonine 12 residue) was found to be phosphorylated in the cytosolic fraction. 
Additionally, in the cytosolic fraction, Ser307 (serine 307 residue) of MmusRAGEv2 was found 
to be phosphorylated. 
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Figure 3.5 MS-based identification of peptide signal intensities of full length RAGE (Tv1-
RAGE). Data were collected from cultured tDRG neurons from WT mice exposed to control and 
LPS conditions. Arbitrary Unit is abbreviated ‘a.u.’. 
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B 
 
Figure 3.6 MS-based peptide identification of RAGE isoforms 1-2 (MmusRAGEv1-2 
abbreviated as ‘v1’ and ‘v2’, respectively). (A) Bar graph membrane and cytosolic fractions of 
MmusRAGEv1 and v2 under control and LPS-treated conditions in WT tDRGs from neonatal 
mice. Top row indicates control and LPS membrane fractions. Bottom row indicates control and 
LPS cytosolic fractions. Arbitrary Unit is abbreviated ‘a.u.’. (B) Total intensities of unique RAGE 
isoform peptides identified by MS-based proteomics from WT tDRGs. 
Accession 
# 
WT MEM 
CTL 
WT MEM CTL Modifications 
Total 
Intensity 
Total Intensity 
(x106) 
322718476 isoform 1 
mETAtGIVDEGTFR  
(N-terminal) 
m:Oxidized methionine 
t:Phosphorylated T 
98700 0.10 
322718478 isoform 2 
ALWVSLGWVR  
(C-terminal) 
none 2030000 2.03 
 
Accession 
# 
WT MEM 
LPS 
WT MEM LPS Modifications 
Total 
Intensity 
Total Intensity 
(x106) 
322718476 isoform 1 Not detected - - - 
322718478 Isoform 2 
ALWVSLGWVR  
(C-terminal) 
none 746000 0.75 
 
Accession 
# 
WT CYT CTL WT CYT CTL Modifications 
Total 
Intensity 
Total Intensity 
(x106) 
322718476 isoform 1 
mETATGIVDEGtFR  
(N-terminal) 
m:Oxidized methionine  
t:Phosphorylated T 
5380000 5.38 
322718478 isoform 2 Not detected - - - 
 
Accession 
# 
WT CYT LPS WT CYT LPS Modifications 
Total 
Intensity 
Total Intensity 
(x106) 
322718476 isoform 1 
mETATGIVDEGtFR  
(N-terminal) 
m:Oxidized methionine 
t:Phosphorylated T 
2740000 2.74 
322718478 isoform 2 
GQLKALWVsLGWVR  
(C-terminal) 
s:Phosphorylated S 1345500 1.35 
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CHAPTER 4 
DISCUSSION & CONCLUSION 
 
Parasympathetic (vagal) and sympathetic (DRG) sensory afferents are known to trigger protective 
reflexes in the upper airways in response to particulate matter and chemical irritants. Under chronic 
inflammatory conditions, these systems have been proposed to become hyperactive and contribute 
to the overproduction of ASL by SGs in the upper airways. At a later stage, airway tissues undergo 
remodelling which drastically worsens mucociliary clearance and enhances bacterial colonization. 
Protective reflex responses in the upper airways have been mostly studied as the result of activation 
of the vagal parasympathetic branch innervating the airways (Bessac and Jordt, 2008; Kollarik et 
al., 2010). In contrast, much less is known about the role of sympathetic afferent DRG neurons in 
these reflex responses. In my research, I studied the sensitization of sympathetic afferent tDRG 
neurons, which innervate SGs in the upper airways (Ianowski et al., 2007; Rogers, 2001; Wine, 
2007). LPS exposure caused sensitization of cultured tDRG neurons, manifested as potentiation of 
CAP-evoked currents and increased action potential generation. These effects require RAGE, and 
the LPS treatment failed to induce sensitization of tDRG neurons from RAGE KO mice (Myint et 
al., 2006). LPS-induced sensitization of tDRG neurons correlates with changes in the expression 
pattern and posttranslational modifications of at least two RAGE isoforms, MmusRAGEv1 and v2 
(Lopez-Diez et al., 2013).  
 
4.1 LPS-mediated sensitization of tDRG neurons 
In the current study, I concentrated on TRPV1-evoked currents, together with evoked action 
potentials, as a tool to monitor excitability in tDRG neurons. TRPV1 sensory transduction plays a 
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major role in sensory signaling in the airways, being expressed in sympathetic (DRG) and 
parasympathetic (vagal) afferents, and contributing not only to nociception but also to the initiation 
of protective reflexes as cough and mucus secretion in response to irritants (Lee and Yu, 2014).  
Here, I investigated the effect of LPS on tDRG neurons known to innervate the upper airways. My 
data revealed that LPS treatment induced the potentiation of TRPV1-evoked currents and 
increased action potential firing in tDRG neurons from wild type mice, where neither of these 
effects were based on changes in resting potential. In contrast, LPS failed to induce these 
sensitization-related changes in tDRG neurons from RAGE KO mice. The lack of effect of LPS 
on neurons from RAGE KO mice suggests that either LPS leads to the expression/production of 
inflammatory mediators that rely on RAGE signalling, or that LPS itself triggers RAGE activation. 
The latter is consistent with the report by Yamamoto et al. (2011) showing that LPS can bind to 
RAGE. LPS is known to act through TLR4 receptors, however, our results suggest that in tDRG 
neurons from RAGE KO mice this pathway may not be active. In fact, it has been recently 
suggested that RAGE and TLRs can cooperate to produce an inflammatory response to some 
shared ligands, such as HMGB1 (Ibrahim et al., 2013). It was previously reported that when TLR4, 
which usually co-localizes with TRPV1 in sensory neurons, is activated by LPS it sensitizes 
TRPV1, resulting in increased pain signaling (Diogenes et al., 2011; Li et al., 2015a). My data 
suggest that RAGE may be required for this effect to take place in tDRG neurons. Activation of 
TLR4 and RAGE lead to shared downstream signaling pathways involving activation of adapter 
proteins MYD88 (myeloid differentiation primary response 88)-NF-κB and MAPK signaling 
cascades (Li et al., 2015b; Yu et al., 2011) supporting my findings of required cooperation or co-
activation of these receptors in tDRG neurons.  
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My study revealed that expression of RAGE during LPS treatment is required for TRPV1 
potentiation and increased excitability of tDRG neurons. It is well accepted that the interaction of 
RAGE with its ligands leads to the production of cytosolic ROS (Ott et al., 2014; Vincent et al., 
2007), which has been particularly studied in the context of diabetes and arteriosclerosis (Coughlan 
et al., 2009; Giacco and Brownlee, 2010). In addition, cytosolic ROS have been shown to 
potentiate CAP-evoked currents by cysteine modification of the TRPV1 channels recovering the 
receptor from agonist-induced desensitization, which was postulated as an underlying mechanisms 
of pain abnormalities (Chuang and Lin, 2009). Thus, tDRG neuron sensitization during LPS 
exposure could be linked to RAGE-induced oxidative stress. A comparison of TRPV1-evoked 
currents in tDRG neurons from WT vs RAGE KO mice showed similar sensitivity to CAP, as the 
EC50 were not significant different. However, neurons from RAGE KO mice had significantly 
smaller peak amplitudes (as well as current density and charge) with respect to those of neurons 
from WT mice at 1, 2.5 and 5 µM CAP. Although, it is unclear at this point the bases of this 
difference, a report from our lab has shown that autonomic neurons from RAGE KO mice have 
lower basal ROS levels than neurons from WT mice (Chandna et al., 2015), which may contribute 
to smaller TRPV1-evoked currents. In addition, it has been reported that TRPV1 channels require 
proto-oncogene tyrosine-protein kinase (Src) function in colonic DRG neurons (Jin et al., 2004), 
therefore, considering that Src is a kinase downstream from RAGE (Sorci et al., 2010), it is 
possible that lack of RAGE expression may have an effect on the basal activity of the TRPV1 
channels. In addition, the basal sensitivity of TRPV1 to chemicals and toxins is thought to be 
modulated by protein kinase C beta type II (PKCβII). RAGE-dependent activation of PKCβII 
allows for the phosphorylation of TRPV1 channels thus increasing its activity and consequent 
sensitization (Mandadi et al., 2011).  
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In the current study we showed that RAGE is required for the increase in neuronal 
excitability during LPS exposure. Previously reported experiments involving LPS-treated colonic 
mouse DRGs also showed increased action potential spiking (Ochoa-Cortes et al., 2010). 
Inflammation at the level of the peripheral terminal is thought to increase action potential spiking 
through changes in voltage-gated sodium channels, potassium channels, chloride inward rectifier 
and calcium channels, however, sodium and potassium channels have been regarded with higher 
importance to this effect. NaV1.8 has been attributed to repetitive firing in DRGs, specifically 
because of its rapid repriming kinetics. Knockout models of NaV1.8 showed normal responses to 
noxious stimuli but exhibited blunted visceral sensitization after topical application of irritants 
(Beyak and Vanner, 2005). RAGE may modulate membrane depolarization through NaV1.8 
(voltage-gated sodium channel subtype 1.8) (Gold and Gebhart, 2010), however, the potential link 
between NaV1.8 and RAGE remains to be addressed. In addition to voltage-gated sodium 
channels, Kv1.4 and 4.2 among other expressed potassium channels are believed to play a role in 
regulating excitability through the modulation of the activation threshold and/or firing rate or 
sustained action potential discharge. These channels have been shown to co-localize with DRGs 
that express TRPV1 and CGRP and appear to influence transient IA type currents. In a model of 
visceral inflammation, a reduction in peak IA current resulted in a hyperpolarizing shift in the 
inactivation curve, indicative of less IA contributing channels available at or near the resting 
membrane potential (Beyak and Vanner, 2005).  
Lipid raft clustering is a long standing phenomena of chronic inflammation, sepsis and 
various other diseases. Lipid rafts, composed of sphingolipids and cholesterol, are dynamic 
assemblies of proteins and lipids that float freely within the lipid bilayer of the cell membrane. 
Ligand binding or oligomerization can cluster or disrupt proteins in or out of rafts. Moreover, 
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certain ligand-activated proteins display increased raft affinity which then initiate downstream 
signalling cascades (Simons and Ehehalt, 2002). One study showed that the binding of AGEs to 
RAGE can increase its trafficking to lipid rafts (Munesue et al., 2013). Coincidentally, cholesterol 
depletion by methyl β-cyclodextrin (mβCD) of TRPV1-containing lipid rafts exhibited reduced 
Ca2+ influx in rat trigeminal sensory neurons following CAP exposure (Szoke et al., 2010). Similar 
outcomes were observed in another study where neuronal excitability was diminished in NaV1.8-
containing lipid rafts of rat DRG neurons that were dissociated with mβCD treatment (Pristerà et 
al., 2012). These evidences point to the possibility that RAGE activation may increase its affinity 
and trafficking to clustered TRPV1- and NaV1.8-contaning lipid rafts that result in increased Ca2+ 
uptake and neuronal excitability. To ascertain if this is due to gene regulation or the inhibition of 
translocation to the cell surface, transcription and expression analyses would need to be performed 
in future experiments. 
 
4.2 Expression of RAGE and its isoforms in tDRG neurons  
Data gathered from the MS analysis identified changes in levels of RAGE and some of its isoforms 
in tDRG neurons from WT mice exposed to LPS. Expression levels of full length RAGE (Tv1-
RAGE) is expected to increase under inflammatory conditions (Chakraborty et al., 2013; Li et al., 
2014), however changes in the expression patterns of RAGE isoforms has not been previously 
explored. From the 17 alternative splice isoforms of RAGE described in mice, two isoforms were 
identified in tDRG, MmusRAGEv1 and v2 (Lopez-Diez et al., 2013). Both isoforms contain the 
first two Ig domains, IgV and IgC2-1 and -2, which form the ligand binding site of the receptor. 
As described by Lopez-Diez et al. (2013), isoform MmusRAGEv1 lacks exon 1, including the 
signal peptide region, and parts of exons 2 and 3, but the rest of the transcript is unaltered including 
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the membrane domain. The detection of MmusRAGEv1 in tDRG samples was surprising, first of 
all, our samples were collected at postnatal days 1-4 and this particular isoform was only found 
before in 11 day old embryonic mice and was not detected in later embryonic stages. The latter, is 
intriguing and may suggest that this protein is expressed in postnatal life. In fact, our MS data 
analyses of posttranslational changes revealed phosphorylation changes in MmusRAGEv1, these 
modifications have not been investigated before and may be associated to changes in the proteome 
that occurs in postnatal life. Second, the transcript for MmusRAGEv1 lacks the signal peptide 
region, which indicates that the translated protein will not be able to enter the intracellular vesicular 
transport system at the endoplasmic reticulum, and therefore, will not insert into the plasma 
membrane (Boron and Boulpaep, 2008). Perhaps this is the reason why we observed higher levels 
of this protein in the cytosol versus membrane, still the presence of a membrane domain is puzzling 
and further studies need to be conducted to better understand the expression and role of this 
isoform. MmusRAGEv2 (Lopez-Diez et al., 2013), which contains the signal peptide domain and 
the first two Ig domains, and a stop codon before exon 10, could generate soluble versions of 
RAGE. The generation of RAGE soluble protein versions have been discussed before, Harashima 
et al. (2006) addressed this possibility by intron 9 retention, and Kang et al. (2014) revealed the 
role of soluble intracellular RAGE isoforms participating downstream of the extracellular signal–
regulated kinases (ERK) in pancreatic cancer cells. The detection of this isoform in tDRG neurons 
is particularly interesting, since its increase in the cytosolic fraction after LPS treatment is 
consistent with possible cytosolic signalling, as shown in pancreatic cancer cells (Kang et al., 
2014). Furthermore, the expression of MmusRAGEv2 in the cytosolic fraction after LPS treatment 
shows phosphorylation in amino acid residue serine 307 (Ser 307), which is reminiscent of the 
serine phosphorylation site identified in full length RAGE (amino acid residue serine 377; Ser 
41 
 
377). In pancreatic cancer cells, Ser377 is a particularly important site that undergoes 
phosphorylation by ERK1/2 (extracellular signal–regulated kinases 1 and 2), phosphorylated 
RAGE is been proposed to accumulate in the mitochondria and modulate ATP biosynthesis  (Kang 
et al., 2014). Thus, a serine phosphorylation site in the vicinity of Ser 377 opens new questions of 
modulation of this isoform that will be addressed in future experiments. At this point, we cannot 
explain the detection of MmusRAGEv2 in the membrane fraction of tDRG neuron samples. Since 
this isoform does not contain a membrane domain, we may be detecting another similar isoform 
or contamination with the cytosolic fraction.  
Different biological processes have been previously reported to remove the transmembrane 
domain and allow the generation of soluble RAGE (sRAGE), either by alternative splicing 
(esRAGE; endogenous secretory RAGE) or proteolytic cleavage (Maillard-Lefebvre et al., 2009) 
of carboxyl-terminal truncation of membrane-bound isoforms (cRAGE; cleaved RAGE) (Hanford 
et al., 2004) by the sheddase ADAM10 (a disintegrin and metalloproteinase domain-containing 
protein 10) (Raucci et al., 2008). The functional association of MmusRAGEv1 and v2 to 
neurogenic inflammation are unknown as this is the first study to identify the isoforms in 
sympathetic afferent tDRG neurons. Most of these isoforms have no physiological function yet. 
Although preliminary, it is interesting to note that MmusRAGEv2 was detected in the tDRG 
membrane fraction, without any changes after LPS treatment. We cannot explain this observation 
at this point, however, this suggests further studies are required to look for residual expression of 
potential cytosolic RAGE isoforms in the RAGE KO mouse.  
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4.3 Challenges  
This work has established RAGE as a key mediator in LPS-induced sensitization of afferent tDRG 
neurons of the upper airway in mice. This was demonstrated from electrophysiological data 
showing the failure of LPS to potentiate CAP-evoked TRPV1 currents and increase action 
potential generation in RAGE KO relative to WT tDRG neurons. MS analysis for protein 
identification represents a step forward in biochemistry, allowing to obtain a global picture of the 
proteins expressed in a cell, including isoforms, post-translational modifications and downstream 
signalling pathways. However, MS also presents multiple limitations and pitfalls, many of which 
were evident during my study. The main reasons why we decided to explore MS as a protein 
identification technique for the expression of RAGE and its isoforms was due to the lack of 
commercially available antibodies for RAGE isoforms and the interest of exploring post-
translational modifications. However, as reviewed by Lubec and Afjehi-Sadat (2007), multiple 
factors can hamper the power of MS, such as the low abundance of protein in the samples tested 
and the complexity of bioinformatic analysis. The expression level of RAGE isoforms (detected 
and not detected) vary significantly among tests, which was likely due to the low abundance of 
protein. In addition, we may have been “blind” to changes in expression levels of RAGE isoforms 
that were not detected by the used MS analysis. The major limiting factor here was the ability to 
obtain high cell numbers given that this study employed primary and not immortalized cell 
cultures. The latter forced us to combined samples collected over a period of 5 months and to 
perform sensitive steps multiple times increasing our chances of cross-contamination. Thus, we 
were not only faced with very low protein concentrations but also we encountered intriguing 
results, such as detecting a cytosolic version of RAGE in the membrane fractions. To confirm the 
findings of this study, qPCR could be performed to not only evaluate the presence and expression 
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of MmusRAGEv1 and v2, but other RAGE isoforms that may be present in tDRGs and undetected 
by MS analysis. The results presented in this thesis were generated as a preliminary analysis of the 
vast amount of data obtained by MS of tDRG neurons exposed to either control or LPS treatment. 
This was the stepping stone that triggered follow up experiments that are currently underway to 
explore the full potential of our samples. Unfortunately, the latter escapes the scope of this thesis 
and have not been included. Thus, the pitfalls listed here, although have affected and limited the 
findings included in this thesis, have also helped us to better design and to optimize the MS analysis 
of the tDRG samples.  
 
4.4 Conclusions and Future Directions 
Given the complexity of neurogenic inflammation and the multi-ligand promiscuity of RAGE, 
further examination of RAGE will need to be done to confirm its interaction (direct or indirect) 
with LPS in vivo and in vitro. This is because it is known that other PRRs such as TLR4 do interact 
with LPS. As yet, there is no compelling evidence to suggest that LPS binds to RAGE in vitro or 
in vivo in sympathetic afferent tDRGs. Although the purpose of this thesis was not to explore the 
interaction of LPS with RAGE or its cascade of mechanisms, the magnitude of response from this 
interaction should be assessed in WT tDRGs with RAGE and TLR4 antagonists. This would help 
confirm the cognate experiments done using RAGE KO tDRGs. The caveat with using a knock-
out model such as the tDRG neurons from RAGE KO mice is that its tissues are biochemically 
different. For instance, RAGE KO peripheral neurons inherently have markedly lower redox states 
under control conditions and such differences may offset responses from LPS-induced 
sensitization. 
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MS analyses have identified isoforms MmusRAGEv1-2 in afferent tDRG neurons 
following LPS treatment. To this effect, siRNA (small interfering RNA) could be designed to 
strategically block the expression of these isoforms before and after LPS exposure in WT tDRGs. 
Calcium imaging to reflect neuronal excitability and electrophysiological experiments to assess 
CAP-evoked TRPV1 potentiation and action potential generation can be studied. Information 
gathered from these in vitro experiments could be extended to ex vivo studies using mouse airway 
explants to study the contribution of tDRG to mucus secretion. Mouse tracheal explants could be 
treated with powdered siRNA (Lam et al., 2012) and observed for changes to ASL levels by in situ 
recording of airway plexuses.  
In vivo experiments manipulating the expression of specific RAGE isoforms by powdered 
siRNA could potentially be used to treat live mice that have been exposed to LPS and their tissues 
assessed for biochemical and other changes. For example, brochoalveolar lavage and tissue 
samples can be obtained and assessed for gross morphological changes, leukocyte counts and 
airway diameter clearance. Mice tracheal explants could also be used to study secretion rates and 
ASL levels. Additionally, MS analysis revealed changes in the expression of two RAGE isoforms 
in WT tDRGs treated with LPS. These isoforms would now require further examination and could 
potentially serve as a targeted strategy in RAGE-associated airway inflammatory diseases. 
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